PODD Form 4: EVP & CFO awarded 11,708 RSUs and options

Rhea-AI Filing Summary

Insulet Corporation reporting insider transactions by EVP & CFO Flavia Pease shows two compensation awards dated 10/01/2025. The filing records a grant of 11,708 restricted stock units (RSUs) settled one-for-one into common shares; these RSUs vest in three equal annual installments beginning one year after the grant. The filing also shows an employee stock option award to buy 1,641 shares at a strike price of $305.98, exercisable in four substantially equal annual installments and expiring 10/01/2035. After the reported RSU grant the reporting person beneficially owned 15,337 shares. Transactions were reported via a Form 4 filed 10/02/2025.

Positive

• 11,708 RSU award aligns executive compensation with shareholder returns through three-year vesting
• 1,641 stock options issued with a clear $305.98 exercise price and long 10/01/2035 expiration, incentivizing long-term performance
• Reporting increases declared beneficial ownership to 15,337 shares, showing disclosed insider holdings

Negative

• None.

Insights

Compensation Analyst

New equity pay package: 11,708 RSUs and 1,641 options awarded on 10/01/2025.

The RSU award of 11,708 shares vests in equal installments over three years and will be settled one-for-one in common stock, aligning the EVP & CFO's interests with shareholders over a multiyear period.

The 1,641 employee stock options carry a $305.98 exercise price, vesting in four equal annual tranches and expiring on 10/01/2035, providing a long-term performance/incentive horizon.

Monitorable item: the disclosed vesting schedule and the 10/01/2035 expiration date define the timeline for potential share issuance and option exercises.

Corporate Governance Expert

Equity grants to a named officer increase reported beneficial ownership to 15,337 shares.

The Form 4 documents how compensation was delivered via RSUs and options rather than cash, which is a governance choice that impacts share-based dilution and executive alignment.

The filing is routine in format and includes explicit vesting and exercise schedules, providing transparency on when equity may convert into outstanding shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Pease Flavia

(Last) (First) (Middle)

C/O INSULET CORPORATION

100 NAGOG PARK

(Street)

ACTON MA 01720

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INSULET CORP [ PODD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & CFO

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/01/2025		A		11,708(1)	A	$0	15,337	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$305.98	10/01/2025		A		1,641		(2)	10/01/2035	Common Stock	1,641	$305.98	1,641	D

Explanation of Responses:

1. Restricted Stock Unit ("RSU") award. RSUs vest in equal installments on each of the first, second and third anniversaries of the grant date and are settled in shares of common stock on a one-for-one basis.

2. The Options become exercisable in substantially equal installments on each of the first, second, third and fourth anniversaries of the grant date.

	/s/ Patricia K. Dolan, attorney-in-fact	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity grants did Insulet (PODD) report for EVP & CFO Flavia Pease?

The Form 4 reports a grant of 11,708 RSUs and an employee stock option for 1,641 shares at a $305.98 exercise price, both dated 10/01/2025.

When do the RSUs and options vest for the reported grants?

The RSUs vest in three equal annual installments starting one year after the grant. The options vest in substantially equal installments over four years.

How many shares does the reporting person beneficially own after the transactions?

Following the reported RSU grant, the filing shows beneficial ownership of 15,337 shares.

What is the option expiration date for the granted stock options?

The employee stock options expire on 10/01/2035 per the Form 4 disclosure.

What filing form and date report these transactions?

The transactions are reported on a Form 4 with the transaction date 10/01/2025 and the form signed/dated 10/02/2025.